Get the Stockscreener App
1.26
0.80%
0.01
Pepgen Inc stock is traded at $1.26, with a volume of 261.89K.
It is up +0.80% in the last 24 hours and down -13.10% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$1.25
Open:
$1.24
24h Volume:
261.89K
Relative Volume:
1.16
Market Cap:
$49.08M
Revenue:
-
Net Income/Loss:
$-87.23M
P/E Ratio:
-0.4242
EPS:
-2.97
Net Cash Flow:
$-82.77M
1W Performance:
+3.28%
1M Performance:
-13.10%
6M Performance:
-57.58%
1Y Performance:
-92.72%
1-Day Range:
$1.2116
$1.29
1-Week Range:
$1.07
$1.29
52-Week Range:
$0.8801
$19.30
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.26 | 49.08M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.85 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.94 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.24 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
250.30 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors - GlobeNewswire
TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors to Secure Counsel Before Important - Bluefield Daily Telegraph
TOP RANKED ROSEN LAW FIRM Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG - GlobeNewswire Inc.
PepGen Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
PepGen Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm - Bluefield Daily Telegraph
PepGen Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before August 8, 2025 to Discuss Your Rights – PEPG - TradingView
Investors who lost money with shares of PepGen Inc. (NASDAQ: - openPR.com
Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain OfficersPEPG - PR Newswire
PEPG INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PepGen Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Securities Lawsuit Alert: PepGen Inc. (PEPG)Contact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Join Class Action to Recover Losses from PepGen Inc. (PEPG)Contact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
PEPG LAWSUIT ALERT: Levi & Korsinsky Notifies PepGen Inc. Investors of a Class Action ... - Eagle-Tribune
PEPG LAWSUIT ALERT: Levi & Korsinsky Notifies PepGen Inc. - GlobeNewswire
Investors Urged to Contact Levi & Korsinsky for Information Before August 8, 2025PepGen Inc. (PEPG) - ACCESS Newswire
PEPGEN INC. (NASDAQ: PEPG) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein - GlobeNewswire
PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Notifies PepGen Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePEPG - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - PR Newswire
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before ... - Eagle-Tribune
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PepGen Inc. - GlobeNewswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds PepGen Inc. (PEPG) Investors of August 8, 2025 Deadline - ACCESS Newswire
PepGen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 8, 2025 to Discuss Your RightsPEPG - Kilgore News Herald
August 8, 2025 Deadline: Join Class Action Lawsuit Against PepGen Inc. (PEPG)Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Urges PepGen Inc. (PEPG) Shareholders to Act Before Lead Plaintiff Deadline August 8, 2025 - ACCESS Newswire
Levi & Korsinsky Reminds PepGen Inc. Investors of the - GlobeNewswire
PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit With Faruqi & Faruqi, LLP - Business Wire
Lost Money on PepGen Inc. (PEPG)? Join Class Action Before August 8, 2025Contact Levi & Korsinsky - ACCESS Newswire
Securities Lawsuit Alert: PepGen Inc. (PEPG) InvestorsContact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
PEPG Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PepGen Inc. - The Malaysian Reserve
PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PepGen Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit – PEPG - TradingView
Shareholders of PepGen Inc. Should Contact The Gross Law Firm Before August 8, 2025 to Discuss Your RightsPEPG - The Malaysian Reserve
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
PEPGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been ... - Bluefield Daily Telegraph
PEPGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
Levi & Korsinsky Notifies PepGen Inc. (PEPG) InvestorsLead Plaintiff Deadline on August 8, 2025 - ACCESS Newswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen - GlobeNewswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG - TradingView
PepGen Inc. (PEPG) LawsuitInvestors Urged to Contact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
PepGen Faces Investor Suit Over Muscular Dystrophy Drug - Law360
Investors in PepGen Inc. (PEPG): Protect Your RightsContact Levi & Korsinsky Before August 8, 2025 - ACCESS Newswire
Levi & Korsinsky Notifies PepGen Inc. (PEPG) Shareholders of Class Action Lawsuit And August 8, 2025 Deadline - ACCESS Newswire
Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025PEPG - StreetInsider
Class Action Filed Against PepGen Inc. (PEPG) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen - GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionPEPG - ACCESS Newswire
PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit - The Malaysian Reserve
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pepgen Inc Stock (PEPG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McArthur James G | President and CEO |
Apr 17 '25 |
Buy |
1.35 |
10,000 |
13,550 |
113,913 |
| McArthur James G | President and CEO |
Apr 08 '25 |
Buy |
1.15 |
41,500 |
47,725 |
103,913 |
| DeLena Mary Beth | General Counsel |
Feb 26 '25 |
Sale |
1.68 |
1,432 |
2,406 |
1,568 |
| Donnelly Noel | Chief Financial Officer |
Feb 26 '25 |
Sale |
1.68 |
1,527 |
2,565 |
1,673 |
| Mellion Michelle L | Chief Medical Officer |
Jul 25 '24 |
Option Exercise |
10.21 |
7,571 |
77,300 |
7,571 |
| Mellion Michelle L | Chief Medical Officer |
Jul 24 '24 |
Option Exercise |
10.21 |
201 |
2,052 |
201 |
| Mellion Michelle L | Chief Medical Officer |
Jul 25 '24 |
Sale |
18.06 |
7,571 |
136,741 |
0 |
| Mellion Michelle L | Chief Medical Officer |
Jul 24 '24 |
Sale |
18.01 |
201 |
3,619 |
0 |
| Mellion Michelle L | Chief Medical Officer |
Jul 18 '24 |
Option Exercise |
10.21 |
12,625 |
128,901 |
12,625 |
| Mellion Michelle L | Chief Medical Officer |
Jul 18 '24 |
Sale |
18.20 |
12,625 |
229,804 |
0 |
2.10%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):